Rates of diagnostic imaging utilization varied by more than 56% across the 10 Medicare regions of the U.S., according to a study presented Wednesday. The regions with the highest utilization had the lowest percentage of imaging services provided by radiologists.
Rates of diagnostic imaging utilization varied by more than 56% across the 10 Medicare regions of the U.S., according to a study presented Wednesday. The regions with the highest utilization had the lowest percentage of imaging services provided by radiologists.
The study looked at trends in noninvasive imaging services provided to Medicare patients using the Medicare Part B fee-for-service database. The survey also analyzed trends over a five-year period ending in 2006.
In 2006, utilization rates per 1000 Medicare beneficiaries ranged from a high of 4532 in the Atlanta region to a low of 2901 in the Seattle region. Radiologists' share of the imaging services provided ranged from 69% in the Boston region to a low of 58% in the Atlanta region.
Plotting the radiologist share against the overall utilization rates showed generally that the higher the utilization rate, the lower the percentage of radiologists providing the services, said Dr. Vijay Rao, chair of radiology at Thomas Jefferson University, who presented the data. The Seattle region, for example, had the lowest utilization rate and lowest percentage of imaging provided by nonradiologists.
Rates of growth in diagnostic imaging ranged from 20% in the New York region to 8% in the Seattle region, Rao said. In all regions of the country, utilization growth is higher among cardiologists than among radiologists or other imaging providers.
During a question and answer session, Rao said more analysis is needed before drawing firm conclusions about the causes of imaging utilization variation and growth.
"One could argue it's all self-referral," she said. "On the other hand, it could be related to density of population, the adoption of technology, or that the radiologists can't meet the demand for imaging and the nonradiologists are filling in."
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.